Teva Pharmaceutical Industries Limited: Business Overview, Financials & Competitive Analysis
Teva Pharmaceutical Industries Limited scores 6/10 on the AskCyborg Cyborg Score (Solid). Diversified global pharma player with strong generic portfolio and specialty brands, trading near fair value with execution risks requiring careful monitoring. Teva reported annual revenue of US$17.26b with net income of US$1.41b and achieved a past 3 months total return of 25.97%. However, the shares trade at a.
What is Teva Pharmaceutical Industries Limited's industry? Teva Pharmaceutical Industries Limited (teva.com) operates in Pharmaceuticals - Generic & Specialty. AskCyborg classifies Teva Pharmaceutical Industries Limited under Pharmaceuticals - Generic & Specialty in its company registry.
Teva Pharmaceutical Industries develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. As a global pharma...
Cyborg Score thesis
Diversified global pharma player with strong generic portfolio and specialty brands, trading near fair value with execution risks...
Read the full analyst-debate transcript →Get the Latest Teva Pharmaceutical Industries Limited Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeTeva Pharmaceutical Industries Limited Overview
Pro stress-test →Teva Pharmaceutical Industries develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. As a global pharmaceutical leader, Teva serves markets across multiple continents with a diverse portfolio spanning generic drugs, specialty pharmaceuticals, and over-the-counter products.
Strategic Profile
Pro stress-test →The company offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms. Teva combines scale in generics with branded specialty pharmaceuticals including COPAXONE for multiple sclerosis, AJOVY for migraine prevention, and AUSTEDO for movement disorders.
Competitive Landscape
Pro stress-test →Teva competes with major pharmaceutical companies including AbbVie, Pfizer, Dr. Reddy's, Roche, and other generic and specialty pharma players. The company maintains competitive advantage through its diversified portfolio spanning both high-volume generics and specialty medications, balanced by geographic diversification and strategic partnerships.
Industry Context
Teva Pharmaceutical Industries Limited operates in Pharmaceuticals - Generic & Specialty.
Key facts
Founded: 1901 · Headquarters: Petah Tikva, Israel · Revenue: $17.3B · Market cap: $39-41B